Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct 23;71(7):1802-1803.
doi: 10.1093/cid/ciaa031.

Chimeric Antigen Receptor T-cell Immunotherapy and Need for Prophylaxis for Invasive Mold Infections

Russell E Lewis  1 , Dimitrios P Kontoyiannis  2
Affiliations
Comment

Chimeric Antigen Receptor T-cell Immunotherapy and Need for Prophylaxis for Invasive Mold Infections

Russell E Lewis et al. Clin Infect Dis. .
No abstract available

PubMed Disclaimer

Comment in

  • Reply to Lewis and Kontoyiannis.
    Haidar G, Nguyen MH, Samanta P. Haidar G, et al. Clin Infect Dis. 2020 Oct 23;71(7):1803-1804. doi: 10.1093/cid/ciaa032. Clin Infect Dis. 2020. PMID: 31926004 No abstract available.

Comment on

References

    1. Haidar G, Dorritie K, Farah R, Bogdanovich T, Nguyen MH, Samanta P. Invasive mold infections after chimeric antigen receptor-modified T-cell therapy: a case series, review of the literature, and implications for prophylaxis [manuscript published online ahead of print 22 November 2019]. Clin Infect Dis 2020; 71:672–6. - PubMed
    1. Georgiadou SP, Pongas G, Fitzgerald NE, et al. Invasive mold infections in pediatric cancer patients reflect heterogeneity in etiology, presentation, and outcome: a 10-year, single-institution, retrospective study. J Pediatric Infect Dis Soc 2012; 1:125–35. - PubMed
    1. Cattaneo C, Monte S, Algarotti A, et al. A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study). J Antimicrob Chemother 2011; 66:2140–5. - PubMed
    1. Cornely OA, Kontoyiannis DP. How to prophylax against invasive fungal infections in adult ALL? An unmet need. Mycoses 2018; 61:646–9. - PubMed
    1. Brunel AS, Wójtowicz A, Lamoth F, et al. Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy. Haematologica 2018; 103:e527–30. - PMC - PubMed

Substances